Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Effects of Methylprednisolone in Infants with Neuroendocrine Cell Hyperplasia
FranceStudy of RMC-6291 and Pembrolizumab with or without Chemotherapy for Patients with Advanced KRAS G12C Mutated Lung Cancer
FranceStudy on Preoperative Treatment with Amivantamab, Carboplatin, and Pemetrexed for Patients with Resectable Non-Small-Cell Lung Cancer with EGFR Mutations
BelgiumStudy on Inhaled Levofloxacin and Sodium Chloride for Patients with Community-Acquired Pneumonia, Including Those with Pre-existing Lung Disease
DenmarkStudy to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
AustriaStudy of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers
SpainStudy of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer
FranceStudy Comparing Dornase Alfa and Alteplase with Surgery for Treating Pleural Empyema in Patients
DenmarkStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
BulgariaStudy on Phospholipid Fraction from Porcine Lung for Premature Infants with Respiratory Distress Syndrome (RDS)
SpainStudy on Nebulized Amikacin for Treating Ventilator-Associated Gram-Negative Pneumonia in Patients on Veno-Arterial ECMO
FranceStudy on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
